Ionis and Akcea launch Phase III trial to treat polyneuropathy

377490098_5a52d301f8_c (1)
Ionis and Akcea have launched a Phase III clinical trial of AKCEA-TTR-L to treat polyneuropathy in patients with hereditary TTR (hATTR) amyloidosis. Credit: Ed Uthman via Flickr.